115 related articles for article (PubMed ID: 24052042)
1. Tissue engineering for in vitro analysis of matrix metalloproteinases in the pathogenesis of keloid lesions.
Li H; Nahas Z; Feng F; Elisseeff JH; Boahene K
JAMA Facial Plast Surg; 2013; 15(6):448-56. PubMed ID: 24052042
[TBL] [Abstract][Full Text] [Related]
2. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
3. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
4. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts.
Uchida G; Yoshimura K; Kitano Y; Okazaki M; Harii K
Exp Dermatol; 2003; 12 Suppl 2():35-42. PubMed ID: 14756522
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts.
Sadick H; Herberger A; Riedel K; Bran G; Goessler U; Hoermann K; Riedel F
Int J Mol Med; 2008 Jul; 22(1):55-60. PubMed ID: 18575776
[TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts.
Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621
[TBL] [Abstract][Full Text] [Related]
7. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
[TBL] [Abstract][Full Text] [Related]
9. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.
Torkian BA; Yeh AT; Engel R; Sun CH; Tromberg BJ; Wong BJ
Arch Facial Plast Surg; 2004; 6(3):180-7. PubMed ID: 15148128
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
11. Elevated prolidase activity in keloids: correlation with type I collagen turnover.
Duong HS; Zhang QZ; Le AD; Kelly AP; Kamdar R; Messadi DV
Br J Dermatol; 2006 May; 154(5):820-8. PubMed ID: 16634881
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin.
Ghaffari A; Li Y; Karami A; Ghaffari M; Tredget EE; Ghahary A
J Cell Biochem; 2006 May; 98(2):383-93. PubMed ID: 16440305
[TBL] [Abstract][Full Text] [Related]
13. A novel three-dimensional model system for keloid study: organotypic multicellular scar model.
Lee WJ; Choi IK; Lee JH; Kim YO; Yun CO
Wound Repair Regen; 2013; 21(1):155-65. PubMed ID: 23231705
[TBL] [Abstract][Full Text] [Related]
14. Disentangling the multifactorial contributions of fibronectin, collagen and cyclic strain on MMP expression and extracellular matrix remodeling by fibroblasts.
Zhang Y; Lin Z; Foolen J; Schoen I; Santoro A; Zenobi-Wong M; Vogel V
Matrix Biol; 2014 Nov; 40():62-72. PubMed ID: 25217861
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
Ries C; Popp T; Egea V; Kehe K; Jochum M
Toxicology; 2009 Sep; 263(1):26-31. PubMed ID: 18809459
[TBL] [Abstract][Full Text] [Related]
16. Low decorin expression along with inherent activation of ERK1,2 in ear lobe keloids.
Meenakshi J; Vidyameenakshi S; Ananthram D; Ramakrishnan KM; Jayaraman V; Babu M
Burns; 2009 Jun; 35(4):519-26. PubMed ID: 19268470
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
18. Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2.
Yeh FL; Shen HD; Lin MW; Chang CY; Tai HY; Huang MH
Burns; 2006 May; 32(3):299-304. PubMed ID: 16487663
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
20. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
